POWERED BY

BIOLOGICSHQ TEAM

BIOLOGICSHQ
TEAM

Robert S. Schwartz, Ph.D. Chair, New York - Bob has extensive experience litigating biotechnology and pharmaceutical patents, including those relating to antibodies, protein biochemistry, molecular biology, genomics and proteomics. Bob has a B.S. in Biology and a Ph.D. in Biochemistry. As a Principal Investigator of grant-funded research he published more than 40 articles in peer-reviewed publications and 7 book chapters.Read Full Bio
Brendan O’Malley, Ph.D. Vice Chair, New York - Brendan has extensive litigation and client counseling experience in technology areas including therapeutic monoclonal antibodies and antibody expression systems, transgenic mice, non-insulin peptide treatments for diabetes, and DNA sequencing. Brendan’s Ph.D. research at Tufts University School of Medicine focused on protein-protein interactions in hepatitis B and hepatitis D virion assembly.Read Full Bio
Corinne E. Atton Associate, New York - Corinne has experience litigating cases concerning a wide range of pharmaceuticals and biotechnology, including DNA sequences, DNA sequencing technologies, recombinant polypeptides, enzyme inhibitors, and antidiabetic drugs.  Corinne has a B.Sc. honors degree in Human Genetics.Read Full Bio
Christopher P. Borello Partner, New York - Chris has extensive experience litigating  and counseling clients on biotechnology and pharmaceutical patents including those relating to fusion proteins, immunomodulators, genetically modified animals, antibodies, chemical compounds, prodrugs and formulations.  Chris has undergraduate and advanced degrees in engineering.Read Full Bio
April M. Breyer Consultant, California - April has litigated various pharmaceutical and biotechnology cases, including concerning oncology treatments and DNA sequencing technology.  She has specialized in damages and commercial success arguments.  April has a B.S. in Genetics, Cell Biology and Development and a B.A. in Physiology.Read Full Bio
Paul Kalish Associate, New York - Paul has experience litigating a variety of pharmaceutical cases, including concerning central nervous system stimulants and immunosuppressants.  Paul has a B.S. in Biomedical Engineering.Read Full Bio
Jordan T. Klimek Associate, New York - Jordan has experience litigating pharmaceutical and biotechnology cases involving siRNA technology, antipsychotics, and bisphosphonates. Jordan’s undergraduate degrees are in Biochemistry and History.Read Full Bio
Christopher E. Loh Partner, New York - Christopher has extensive experience counseling clients and litigating matters involving biotechnology and life sciences, including in the areas of antibody biosimilars, targeted cancer therapies, diabetes treatments and siRNA technologies.  Christopher has a B.S. in Molecular Biochemistry and Biophysics and in Economics from Yale University.Read Full Bio
Sean McDonagh Associate, New York - Sean has experience litigating and prosecuting biologics, biotechnology and pharmaceutical patents. Sean has a B.S. in Human Biology, and an M.S. in Physiology.  His graduate work focused on the neurophysiology of the glucagon-like peptide hormones and was published in the American Journal of Physiology.Read Full Bio
Michael P. McGraw Partner, New York - Mike has a large breadth of experience litigating matters that include biotechnology, chemical and pharmaceutical products.  Mike has a B.S. in Biochemistry and worked as a chemist for more than 6 years before joining Fitzpatrick.Read Full Bio
Whitney Meier Associate, New York - Whitney has experience litigating biochemistry, biotechnology, and pharmaceutical formulation patents.  Whitney was awarded a B.S. degree in Biochemistry with high distinction.Read Full Bio
Frederick Millett Associate, New York - Fred has litigated a variety of patents with a focus on biotechnology, chemistry, and pharmaceuticals, in particular concerning HIV/AIDS treatments.  Fred has a B.S. degree in Chemical Engineering.Read Full Bio
Erica L. Norey Associate, New York - Erica has experience in complex patent litigation under the Hatch-Waxman Act and interference proceedings.  Erica has a B.S. in Biology and Anthropology.Read Full Bio
Scott K. Reed Partner, New York - Scott is the Chairman of the Litigation Practice Group.  Scott has more than 30 years of trial experience and has served as lead trial counsel in a wide range of complex biotechnology, pharmaceutical, and chemical cases, including those relating to cell-based biotechnology assays, fusion proteins, and angiogenesis.   Scott's undergraduate degrees are in Chemistry and Economics.Read Full Bio
Simon D. Roberts Partner, New York - Simon has extensive experience counseling clients and litigating a wide variety of matters involving biotechnology and life sciences, including in the areas of depsipeptide cancer therapies, echinocandin antifungal therapies, and a host of small molecule treatments concerning various disease conditions.  Simon has a B.Sc. honors degree in Chemistry.Read Full Bio
Alicia A. Russo Partner, New York - Alicia has extensive experience litigating and prosecuting biologics, biotechnology, bioinformatics and pharmaceutical patents.  She has a B.S. in Biology and Chemistry, and an M.S. in Biomedical Sciences.  Alicia has published original papers in Science, Nature, Cell and the Proceedings of the National Academia of Sciences.Read Full Bio
Chika S. Seidel Associate, New York - Chika has experience litigating and counseling clients on matters involving life sciences and pharmaceutical patents.  She also has first-hand experience in biochemical research in the areas of HIV, cancer, and neuroscience.  Chika received a B.A. in Chemistry with the highest distinction, and has studied genetics and graduate-level biochemistry and synthetic organic chemistry.Read Full Bio
David Varghese Associate, New York - David focuses on patent litigation in the chemical and pharmaceutical arts.  He has a B.S. in Cell and Molecular Biology.  Prior to attending law school, David worked in Cancer Biology at the University of Texas MD Anderson Cancer Center.Read Full Bio
Stephen K. Sullivan, Ph.D. Partner, New York - Steve has extensive experience counseling on, procuring, and litigating a wide range of biotechnology patents including those relating to antibodies, anti-cancer therapies, and treatments for orphan and ultra-rare diseases.  Steve earned a B.A. in Biology and in Chemistry, a Ph.D. in Physiology, and completed a Postdoctoral Fellowship in Molecular Biology and Electrophysiology at Columbia University.Read Full Bio
Ha Kung Wong Partner, New York - Ha Kung has extensive experience litigating a wide variety of pharmaceutical cases, including those concerning biologics used to treat rheumatoid arthritis and autoimmune disorders.  He also has extensive experience consulting, conducting due diligence and licensing pharmaceutical portfolios.  Ha Kung has a B.S. in Biochemistry and a B.S. in Chemistry.Read Full Bio

METHODOLOGY

Information contained in the Fitzpatrick BiologicsHQ database relates to FDA-approved drug products listed in the CDER Purple Book or on the FDA website (www.fda.gov). Information relating to FDA licensed products, FDA-approved indications, and aBLA and 505(b)(2) applications is obtained from public sources including the U.S. FDA website (www.fda.gov). Information relating to litigations is given only for cases active from January 31, 2010 onward. Information relating to foreign biosimilar / biologics follow-on products approved in Australia, Canada, the E.U., Japan and South Korea is from public sources. Statistics Graphics are compiled from information contained in the Fitzpatrick BiologicsHQ database.

DISCLAIMER

BiologicsHQ and materials published on BiologicsHQ are published for informational purposes only. Neither the information nor any opinion expressed on BiologicsHQ constitute legal advice, create an attorney-client relationship, or constitute a solicitation for business. Links or references to third party sites or resources are provided for informational purposes only.

SUBSCRIBE FOR FUTURE UPDATES

captcha